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ALUMNIAWARDS
THE RALPH BRINSTER  
LIFETIME ACHIEVEMENT AWARD
Created in 2011 by the Dean’s Alumni Council, the Ralph Brinster Lifetime Achievement 
Award is Penn Vet’s highest award of recognition.  
 
As demonstrated by its first recipient, Dr. Ralph Brinster, this award recognizes 
outstanding individuals who have shown innovation, excellence, and leadership in the 
veterinary profession both nationally and internationally.
The 2013 recipient of the Ralph Brinster Lifetime Achievement Award is Dr. David 
Nunamaker, V’68, who received a standing ovation at the award ceremony during the 
Penn Annual Conference.
Dr. Nunamaker is the retired University of Pennsylvania School of Veterinary Medicine 
Jacques Jenny Professor of Orthopaedic Surgery.  In this role, he tirelessly pursued a 
greater understanding of the mechanics of bone modeling and remodeling in horses, 
based on various types of exercise surfaces, and designed a now widely used external 
fixation device for horses suffering catastrophic leg fractures.
Dr. Nunamaker served as Director of the Richard S. Reynolds Comparative Orthopaedic 
Research Laboratory, where he conducted in-depth research into many conditions 
affecting Thoroughbreds and Standardbred racehorses.  His work offered the racing 
industry enlightened alternatives to traditional training methods that would benefit 
the horse. 
He established two patents for external skeletal 
fixation and researched bucked shins for over 18 
years with more than one million dollars in support 
from the USDA, NIH, and private and industry 
funding.  Through his research, Dr. Nunamaker 
developed a plan to prevent bucked shins, which 
could reduce the incidence of this condition from 
70-90 percent to less than five percent.
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